| Good Samaritan Society - Hays | |
| 2700 Canal Blvd, Hays, Kansas 67601 | |
| (785) 625-7331 | |
| Name | Good Samaritan Society - Hays |
|---|---|
| Location | 2700 Canal Blvd, Hays, Kansas |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 70 |
| Occupancy Rate | 62.86% |
| Medicare ID (CCN) | 175322 |
| Legal Business Name | The Evangelical Lutheran Good Samaritan Society |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1770573214 |
| Organization Name | THE EVANGELICAL LUTHERAN GOOD SAMARITAN SOCIETY |
| Doing Business As | GOOD SAMARITAN SOCIETY - HAYS |
| Address | 2700 Canal Blvd, Hays, KS 67601 |
| Phone Number | 785-625-7331 |
News Archive
Loyola University Health System has teamed up with ProActiveKids Foundation to help children and their families in the battle against obesity by offering a free program for children who have a body mass index (BMI) in the 85th percentile or higher.
Federation of American Societies for Experimental Biology (FASEB) President Mark O. Lively, Ph.D., addressed a Capitol Hill audience, including congressional staff, and members of the Coalition for Health Funding today to describe the critical role biomedical research plays in improving public health.
The U.S. plans to support efforts to develop a sustainable health system in Zimbabwe and increase its capacity to treat people, Eric Goosby, U.S. global AIDS Coordinator for PEPFAR, said on Wednesday after a visit to the country with USAID and CDC officials, according to a press release from the U.S. Embassy in Harare, Zimbabwe. Goosby said he is "optimistic" that the Zimbabwe PEPFAR team's experience will be used "to develop a response that fits the existing health infrastructure, supports it and reinforces it in a way that creates a durable and lasting response" (9/2).
Clementia Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track designation to palovarotene, which is being developed for the treatment of fibrodysplasia ossificans progressiva (FOP).
A new landmark clinical trial shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Loyola University Health System has teamed up with ProActiveKids Foundation to help children and their families in the battle against obesity by offering a free program for children who have a body mass index (BMI) in the 85th percentile or higher.
Federation of American Societies for Experimental Biology (FASEB) President Mark O. Lively, Ph.D., addressed a Capitol Hill audience, including congressional staff, and members of the Coalition for Health Funding today to describe the critical role biomedical research plays in improving public health.
The U.S. plans to support efforts to develop a sustainable health system in Zimbabwe and increase its capacity to treat people, Eric Goosby, U.S. global AIDS Coordinator for PEPFAR, said on Wednesday after a visit to the country with USAID and CDC officials, according to a press release from the U.S. Embassy in Harare, Zimbabwe. Goosby said he is "optimistic" that the Zimbabwe PEPFAR team's experience will be used "to develop a response that fits the existing health infrastructure, supports it and reinforces it in a way that creates a durable and lasting response" (9/2).
Clementia Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track designation to palovarotene, which is being developed for the treatment of fibrodysplasia ossificans progressiva (FOP).
A new landmark clinical trial shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $58514 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 20.73 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.94 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 30.56 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.42 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 9.72 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.18 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.21 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.9 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.41 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 78.45 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.63 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 30.69 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.7 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.14 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.6 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 94.9 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 73.39 | 82.93 |
News Archive
Loyola University Health System has teamed up with ProActiveKids Foundation to help children and their families in the battle against obesity by offering a free program for children who have a body mass index (BMI) in the 85th percentile or higher.
Federation of American Societies for Experimental Biology (FASEB) President Mark O. Lively, Ph.D., addressed a Capitol Hill audience, including congressional staff, and members of the Coalition for Health Funding today to describe the critical role biomedical research plays in improving public health.
The U.S. plans to support efforts to develop a sustainable health system in Zimbabwe and increase its capacity to treat people, Eric Goosby, U.S. global AIDS Coordinator for PEPFAR, said on Wednesday after a visit to the country with USAID and CDC officials, according to a press release from the U.S. Embassy in Harare, Zimbabwe. Goosby said he is "optimistic" that the Zimbabwe PEPFAR team's experience will be used "to develop a response that fits the existing health infrastructure, supports it and reinforces it in a way that creates a durable and lasting response" (9/2).
Clementia Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track designation to palovarotene, which is being developed for the treatment of fibrodysplasia ossificans progressiva (FOP).
A new landmark clinical trial shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.
› Verified 1 days ago